Roche secures Zealand pharma’s obesity drug in $5.3 billion deal
HQ Team March 12, 2025: Swiss pharmaceutical giant Roche has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma to.
Pharma
Drugs
Health
Pharma
Roche to acquire US-based Poseida Therapeutics for $1.5 billion
Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.
Climate
Health
Pharma
European body to teach medical students health risks from climate change
Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future.
Drugs
Health
Pharma
Roche ends small cell lung cancer trials as results show ‘reduced efficacy’
Swiss drugmaker, Roche, halted a lung cancer trial after it failed to meet the goal of progression-free survival compared to an existing treatment.
Drugs
Health
Pharma
Roche, Alnylam to jointly develop hypertension therapy
HQ Team July 25, 2023: Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to.
Drugs
Pharma
Roche’s Alzheimer’s drug fails to meet primary target
Roche, a Swiss drugmaker, announced its Alzheimer's drug did not meet the primary goal of slowing the disease during two clinical trials